Category: Rectal cancer

Home / Rectal cancer

Categories

Chronic liver disease increases the risk of colorectal cancer

A systematic review and me of Sakuraba and other reports from the University of Chicagota analysis results show that patients with chronic liver disease have a higher risk of colorectal cancer (CRC), ...

Nuclear drugs to target and eliminate colorectal cancer

Researchers at Memorial Sloan Kettering Cancer Center and the Massachusetts Institute of Technology have developed a new three-step system that uses nuclear drugs to target and eliminate colorectal ca...

Fiber intake reduces mortality in patients with non-metastatic colorectal cancer

Mingyang Song of Harvard Medical School and Massachusetts General Hospital reported that after diagnosis of non-metastatic colorectal cancer, ingesting more fiber will reduce the specific mortality an...

Adding SIRT to chemotherapy can improve survival in colorectal cancer

Colorectal cancerThe researchers found that adding SIRT to chemotherapy can improve the survival rate of colorectal cancerNew research shows that for patients with colorectal cancer who have only li...

American Mayo Clinic experts talk about the treatment of rectal cancer

Rectal cancer is cancer that occurs in the last few inches of the colon. This area is called the rectum. The main treatment for rectal cancer is surgery. Depending on the progress of the cancer, r...

Treatment strategy for oligometastatic advanced colorectal cancer

The concept of oligometastasis was proposed by Hellman in 1995. He pointed out that the lesion refers to  some intermediate states between the localized growth of the tumor and  systemic metastasis...

Anti-PD-L1 immunotherapy combined with MEK inhibitor for metastatic colorectal cancer

At the 18th World Congress of Gastrointestinal Cancer, a phase I clinical study showed that anti-PD-L1 immunotherapy combined with MEK inhibitors can effectively treat microsatellite stable metastatic...

Application and evaluation of KRAS gene mutation method for colorectal cancer

Targeting drugs such as cetuximab and panitumumab have been widely used in clinic as effective therapeutic drugs for colorectal cancer. Clinical data show that patients with KRAS mutations have no si...

Lonsurf for the treatment of refractory metastatic colorectal cancer

Japanese pharmaceutical company Otsuka (Otsuka) recently received good news in the US regulatory aspects, FDA approved anti-cancer compound new drug Lo 3 ​​months in advancensurf (trifluridine / t...

Scan the code